You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

branch retinal vein occlusion

Showing 1 - 25 of 8,023
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Branch Retinal Vein Occlusion Trial in Damietta (aflibercept (2mg/0.05ml))

Completed
  • Branch Retinal Vein Occlusion
  • aflibercept (2mg/0.05ml)
  • Damietta, Egypt
    Akram Fekry Elgazzar
Nov 22, 2023

Branch Retinal Vein Occlusion, Ranibizumab, Laser Photocoagulation Trial in Beijing (Ranibizumab combined macular laser,

Completed
  • Branch Retinal Vein Occlusion
  • +2 more
  • Beijing, Beijing, China
    Beijing Hospital
Dec 25, 2022

Branch Retinal Vein Occlusion, Macular Edema Trial in Odense, Roskilde (Aflibercept Injection [Eylea], Navigated laser

Completed
  • Branch Retinal Vein Occlusion
  • Macular Edema
  • Aflibercept Injection [Eylea]
  • Navigated laser photocoagulation
  • Odense, Danmark, Denmark
  • +1 more
Apr 18, 2022

Functional Optical Coherence Tomography for Ocular Imaging

Completed
  • Glaucoma
  • +4 more
  • Optical Coherence Tomography
  • Irvine, California
    Beckman Laser Institute, University of California,Irvine
Oct 19, 2022

Retinal Vein Occlusion Trial in Bethesda, Bristol (Minocycline, Placebo, Bevacizumab)

Completed
Has Results
  • Retinal Vein Occlusion
  • Bethesda, Maryland
  • +1 more
Dec 27, 2021

Glaucoma, Glaucoma Suspect, Diabetic Retinopathy Trial in Philadelphia (Free Eye Screenings, Enhanced Intervention, Usual Care)

Completed
Has Results
  • Glaucoma
  • +12 more
  • Free Eye Screenings
  • +2 more
  • Philadelphia, Pennsylvania
    Wills Eye Glaucoma Service
Aug 19, 2022

Branch Retinal Vein Occlusion, Retinal Blood Flow, Retinal Oxygen Saturation Trial in Vienna (Dynamic Vessel Analyzer,

Recruiting
  • Branch Retinal Vein Occlusion
  • +2 more
  • Dynamic Vessel Analyzer
  • Bidirectional Fourier-Domain Optical Coherence Tomography (FDOCT)
  • Vienna, Austria
    Department of Clinical Pharmacology, Medical University of Vienn
Apr 6, 2022

Use of Aflibercept Injections Into Eye for Treatment of Eye

Recruiting
  • Retinal Disease
  • Aflibercept (BAY86-5321, Eylea)
  • Multiple Locations, Mexico
    Many locations
Aug 22, 2022

Central Retinal Vein Occlusion With Macular Edema, Branch Retinal Vein Occlusion With Macular Edema Trial in Taiwan (TLC399)

Completed
Has Results
  • Central Retinal Vein Occlusion With Macular Edema
  • Branch Retinal Vein Occlusion With Macular Edema
  • Chang Hua, Taiwan
  • +5 more
Nov 24, 2021

Diabetic Macular Edema, Branch Retinal Vein Occlusion, Glaucoma/Closed Angle Glaucoma Trial in Tampa (IRX-101, Control)

Terminated
  • Diabetic Macular Edema
  • +2 more
  • Tampa, Florida
    Florida
May 17, 2022

Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in Springfield,

Active, not recruiting
  • Age-Related Macular Degeneration
  • +4 more
  • bevacizumab
  • Springfield, Illinois
  • +2 more
Dec 6, 2021

Retinal Vein Occlusion, Diabetic Macular Edema, Branch Retinal Vein Occlusion Trial in Cleveland (Aflibercept)

Completed
Has Results
  • Retinal Vein Occlusion
  • +3 more
  • Cleveland, Ohio
    Cole Eye Institute, Cleveland Clinic
May 10, 2021

Branch Retinal Vein Occlusion With Macular Edema Trial in Stockholm (Aflibercept Injection [Eylea], Ranibizumab Injection

Recruiting
  • Branch Retinal Vein Occlusion With Macular Edema
  • Aflibercept Injection [Eylea]
  • Ranibizumab Injection [Lucentis]
  • Stockholm, Sweden
    St Eriks Eye Hospital
Dec 2, 2020

Branch Retinal Vein Occlusion Trial in BeiJing (601 1.25mg, Ranibizuman 0.5 mg)

Not yet recruiting
  • Branch Retinal Vein Occlusion
  • 601 1.25mg
  • Ranibizuman 0.5 mg
  • BeiJing, Beijing, China
    BeiJing Hospital
Dec 8, 2020

Branch Retinal Vein Occlusion Trial in Shenyang (Bevacizumab Ophthalmic and Intravitreal Dexamethasone, Bevacizumab Ophthalmic)

Unknown status
  • Branch Retinal Vein Occlusion
  • Bevacizumab Ophthalmic and Intravitreal Dexamethasone
  • Bevacizumab Ophthalmic
  • Shenyang, Liaoning, China
    He Eye Specialist Hospital
Oct 20, 2020

Branch Retinal Vein Occlusion Trial in Worldwide (Brolucizumab 6 mg, Aflibercept 2 mg, Sham injection)

Terminated
Has Results
  • Branch Retinal Vein Occlusion
  • Brolucizumab 6 mg
  • +2 more
  • Phoenix, Arizona
  • +101 more
Jan 27, 2023

Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States

Completed
  • Age-related Macular Degeneration
  • +4 more
  • bevacizumab
  • Tucson, Arizona
  • +19 more
Nov 16, 2021

Retinal Vein Occlusion Trial in France

Active, not recruiting
  • Retinal Vein Occlusion
    • Créteil, France
    • +8 more
    Aug 17, 2022

    Macular Edema, Branch Retinal Vein Occlusion Trial in Worldwide (Faricimab, Aflibercept, Sham Procedure)

    Active, not recruiting
    • Macular Edema
    • Branch Retinal Vein Occlusion
    • Phoenix, Arizona
    • +151 more
    Aug 4, 2022

    Retinal Vein Occlusion, Obstructive Sleep Apnea Trial in Orléans (Sleeping Monitor)

    Withdrawn
    • Retinal Vein Occlusion
    • Obstructive Sleep Apnea
    • Sleeping Monitor
    • Orléans, France
      CHR d'Orléans
    Oct 20, 2021

    Central Retinal Vein Occlusion With Macular Edema Trial in Peshawar (Group A)

    Completed
    Has Results
    • Central Retinal Vein Occlusion With Macular Edema
    • Group A
    • Peshawar, KPK, Pakistan
      Hayatabad Medical Complex
    Apr 3, 2022

    Retinal Vein Occlusion Trial in Winston-Salem (Aflibercept Ophthalmic)

    Recruiting
    • Retinal Vein Occlusion
    • Aflibercept Ophthalmic
    • Winston-Salem, North Carolina
      Wake Forest Health Sciences
    Jan 5, 2022

    Retinal Vein Occlusion Trial in Damietta (Triamcinolone Acetonide)

    Completed
    • Retinal Vein Occlusion
    • Triamcinolone Acetonide
    • Damietta, Egypt
      Akram Fekry Elgazzar
    Apr 21, 2022

    Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Shanghai (BD311)

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • +2 more
    • BD311
    • Shanghai, Shanghai, China
      Eye & ENT Hospital of Fudan University
    Aug 22, 2022

    Artificial Intelligence Diagnostic Aid

    Not yet recruiting
    • Wet Macular Degeneration
    • +2 more
    • Macusense Assessment Software
    • London, Westminster, United Kingdom
      Guy's and St Thomas's NHS Foundation Trust
    Dec 29, 2022